Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 192 pseudogene is a sequence in the human genome annotated as a pseudogene of the parent gene centrosomal protein 192 (CEP192). Pseudogenes are defined as genomic regions with high sequence similarity to functional genes but typically lack the ability to produce functional proteins due to disabling mutations or absence of regulatory elements[3][5]. In most annotation systems, pseudogenes are not considered direct therapeutic targets, nor do they encode receptors, enzymes, transporters, or other functional biomolecules typically relevant to drug discovery[5]. However, recent research indicates that some pseudogenes may have regulatory roles, such as acting as decoys for miRNAs or influencing chromatin structure, but functional evidence is needed and is generally target-specific, not universally applicable to all pseudogenes[1][7]. There is no current evidence for centrosomal protein 192 pseudogene (ENSG00000262187) being a functional molecule, druggable target, biomarker, or disease-linked locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on centrosomal protein 192 pseudogene.